Paper39153293
Adverse events following immunization (AEFI) with fractional one-fifth and one-half doses of yellow fever vaccine compared to full dose in children 9-23 months old in Uganda, 2019-2020 - Preliminary report.
Casey RM and 10 others. Vaccine, 2024. Cited by 5 papers, by iCite.
Cite this record
ConductScience Library. Adverse events following immunization (AEFI) with fractional one-fifth and one-half doses of yellow fever vaccine compared to full dose in children 9-23 months old in Uganda, 2019-2020 - Preliminary report. Papers, record 39153293. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39153293
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
Adverse events following immunization (AEFI) with fractional one-fifth and one-half doses of yellow fever vaccine compared to full dose in children 9-23 months old in Uganda, 2019-2020 - Preliminary report.
- PubMed
- Publication types
- Journal Article, Randomized Controlled Trial, Research Support, U.S. Gov't, P.H.S.
- PubMed
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Yellow Fever Vaccine | Major topic |
| Yellow Fever | Major topic |
| Humans | |
| Infant | |
| Uganda | |
| Male | |
| Female | |
| Single-Blind Method | |
| Vaccination | |
| Drug-Related Side Effects and Adverse Reactions | |
| Immunization Schedule |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| CC999999 | Intramural CDC HHS | United States | PubMed |
Source PubMed
References30
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 31859201 | Immunogenicity and safety of fractional dose yellow fever vaccination: A systematic review and meta-analysis. | Vaccine | 2020 | https://conductscience.org/library/papers/31859201 | PubMed |
| 2 | 30475808 | Variation in the quality and out-of-pocket cost of treatment for childhood malaria, diarrhoea, and pneumonia: Community and facility based care in rural Uganda. | PLoS One | 2018 | https://conductscience.org/library/papers/30475808 | PubMed |
| 3 | 33656136 | Adverse events following yellow fever vaccination in immunocompromised persons. | Rev Inst Med Trop Sao Paulo | 2021 | https://conductscience.org/library/papers/33656136 | PubMed |
| 4 | 26086636 | Yellow Fever Vaccine Booster Doses: Recommendations of the Advisory Committee on Immunization Practices, 2015. | MMWR Morb Mortal Wkly Rep | 2015 | https://conductscience.org/library/papers/26086636 | PubMed |
| 5 | 27784992 | Yellow fever vaccine-associated viscerotropic disease: current perspectives. | Drug Des Devel Ther | 2016 | https://conductscience.org/library/papers/27784992 | PubMed |
| 6 | 27378369 | Adverse event reports following yellow fever vaccination, 2007-13. | J Travel Med | 2016 | https://conductscience.org/library/papers/27378369 | PubMed |
| 7 | 21640779 | Mutual interference on the immune response to yellow fever vaccine and a combined vaccine against measles, mumps and rubella. | Vaccine | 2011 | https://conductscience.org/library/papers/21640779 | PubMed |
| 8 | 893464 | Stabilized 17D strain yellow fever vaccine: dose response studies, clinical reactions and effects on hepatic function. | J Biol Stand | 1977 | https://conductscience.org/library/papers/893464 | PubMed |
| 9 | 18809449 | Adverse event reports following yellow fever vaccination. | Vaccine | 2008 | https://conductscience.org/library/papers/18809449 | PubMed |
| 10 | 15837230 | Yellow fever vaccine: an updated assessment of advanced age as a risk factor for serious adverse events. | Vaccine | 2005 | https://conductscience.org/library/papers/15837230 | PubMed |
| 11 | 20671663 | Yellow fever vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP). | MMWR Recomm Rep | 2010 | https://conductscience.org/library/papers/20671663 | PubMed |
| 12 | 33422245 | Immunogenicity and safety of fractional doses of yellow fever vaccines: a randomised, double-blind, non-inferiority trial. | Lancet | 2021 | https://conductscience.org/library/papers/33422245 | PubMed |
| 13 | 24456625 | Yellow fever vaccine-associated adverse events following extensive immunization in Argentina. | Vaccine | 2014 | https://conductscience.org/library/papers/24456625 | PubMed |
| 14 | 26090855 | Serious adverse events associated with yellow fever vaccine. | Hum Vaccin Immunother | 2015 | https://conductscience.org/library/papers/26090855 | PubMed |
| 15 | 30937437 | Fractional-dose yellow fever vaccination: an expert review. | J Travel Med | 2019 | https://conductscience.org/library/papers/30937437 | PubMed |
| 16 | 3372545 | Studies on yellow fever vaccine. III--Dose response in volunteers. | J Biol Stand | 1988 | https://conductscience.org/library/papers/3372545 | PubMed |
| 17 | 12941972 | Prevalence of childhood illnesses and care-seeking practices in rural Uganda. | ScientificWorldJournal | 2003 | https://conductscience.org/library/papers/12941972 | PubMed |
| 18 | 16632108 | Innate and adaptive cellular immunity in flavivirus-naïve human recipients of a live-attenuated dengue serotype 3 vaccine produced in Vero cells (VDV3). | Vaccine | 2006 | https://conductscience.org/library/papers/16632108 | PubMed |
| 19 | 23395587 | Adverse events following yellow fever preventive vaccination campaigns in eight African countries from 2007 to 2010. | Vaccine | 2013 | https://conductscience.org/library/papers/23395587 | PubMed |
| 20 | 28358792 | Notes from the Field: Adverse Events Following a Mass Yellow Fever Immunization Campaign - Kongo Central Province, Democratic Republic of the Congo, September 2016. | MMWR Morb Mortal Wkly Rep | 2017 | https://conductscience.org/library/papers/28358792 | PubMed |
Cited by4
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 5 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42627790 | Determinants of post-campaign measles vaccination coverage in Madagascar: A geographically stratified analysis. | PLOS Glob Public Health | 2026 | https://conductscience.org/library/papers/42627790 | PubMed |
| 42136579 | Factors associated with serious adverse event following immunization: a real-world analysis of the vaccine adverse event reporting system 2025. | Front Public Health | 2026 | https://conductscience.org/library/papers/42136579 | PubMed |
| 41512502 | Adverse events following immunization (AEFI) with fractional one-fifth and one-half doses of yellow fever vaccine compared to standard dose in children 9-23 months old in Uganda, 2019-2022 - final report. | Vaccine | 2026 | https://conductscience.org/library/papers/41512502 | PubMed |
| 40907498 | Strengthening New Vaccine Introduction in Low- and Middle-Income Countries: Establishing Hospital-Based Sentinel Surveillance for Vaccine Safety Monitoring. | Am J Trop Med Hyg | 2025 | https://conductscience.org/library/papers/40907498 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39153293
GET https://conductscience.org/api/papers/v1/39153293/references?page=2